Judicious DICER1 testing and surveillance imaging facilitates early diagnosis and cure of pleuropulmonary blastoma

Pediatric Blood and Cancer

Volumn 61, Issue 9, 2014, Pages 1695-1697

  Schultz, Kris Ann P ^a   Harris, Anne ^a   Williams, Gretchen M ^a   Baldinger, Shari ^a,b   Doros, Leslie ^a,c   Valusek, Patricia ^a,d   Frazier, A Lindsay ^a,e   Dehner, Louis P ^a,f   Messinger, Yoav ^a   Hill, D Ashley ^a,c,g  

^a CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^b Virgina Piper Cancer Institute   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d Pediatric Surgical Associates   (United States)

^e Dana Farber Boston Children's Cancer and Blood Disorders Center   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

DICER1; Genetic testing; Lung cysts; Pleuropulmonary blastoma; Sertoli Leydig cell tumor

Indexed keywords

DICER; DICER1; UNCLASSIFIED DRUG;

ADULT; ANDROBLASTOMA; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; FEMALE; GENETIC SCREENING; HUMAN; LOSS OF FUNCTION MUTATION; LUNG BLASTOMA; LUNG LOBECTOMY; OVARIECTOMY; PLEURA CANCER; PLEUROPULMONARY BLASTOMA; PRIORITY JOURNAL;

DICER1; GENETIC TESTING; LUNG CYSTS; PLEUROPULMONARY BLASTOMA; SERTOLI-LEYDIG CELL TUMOR;

ADULT; CHILD, PRESCHOOL; DEAD-BOX RNA HELICASES; EARLY DIAGNOSIS; FEMALE; GERM-LINE MUTATION; HUMANS; INFANT; MALE; PROGNOSIS; PULMONARY BLASTOMA; RIBONUCLEASE III; SERTOLI-LEYDIG CELL TUMOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84904438192     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25092     Document Type: Article

References (20)

1. Hill DA, Jarzembowski JA, Priest JR, et al. Type I pleuropulmonary blastoma: Pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol 2008; 32:282-295.
2. Priest JR, Williams GM, Hill DA, et al. Pulmonary cysts in early childhood and the risk of malignancy. Pediatr Pulmonol 2009; 44:14-30.
3. Messinger YH, Schultz KAP, Dehner LP. Uncommon pediatric tumors of the thorax. Textbook of Uncommon Cancer, pp. 877-901.
4. Williams GM, Priest JR, Finkelstein MJ, et al. Effect of radiation on outcome of types II and III PPB: A report from the international pleuropulmonary blastoma registry [abstract]. J Clin Oncol 2012; 30S:9521.
5. Ferrari A, Bisogno G, De Salvo GL, et al. The challenge of very rare tumours in childhood: The Italian TREP project. Eur J Cancer 2007; 43:654-659.
6. Hill DA, Ivanovich J, Priest JR, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009; 325:965-967.
7. Doros L, Yang J, Dehner L, et al. DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome. Pediatr Blood Cancer 59:558-560.
8. Schultz KA, Yang J, Doros L, et al. DICER1-pleuropulmonary blastoma familial tumor predisposition syndrome: A unique constellation of neoplastic conditions. Pathol Case Rev 2014; 19:90-100.
9. Rio Frio T, Bahubeshi A, Kanellopoulou C, et al. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. JAMA 2011; 305:68-77.
10. Doros LA, Rossi CT, Yang J, et al. DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Mod Pathol 2014; 1-14.
11. Pugh TJ, Yu W, Yang J, et al: Progressive biallelic loss of TP53 is associated with progression of pleuropulmonary blastoma initiated by germline loss and somatic mutation of DICER1. In: Proceedings of the 104th annual meeting of the American Association for Cancer Research. Philadelphia, PA; 2013.
12. Doros LA, Yang J, Field A, et al. Pleuropulmonary blastoma: The causative role of germline DICER1 mutations [abstract]. J Clin Oncol 2013; 31:10024.
13. Heravi-Moussavi A, Anglesio MS, Cheng SW, et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 366:234-242.
14. Witkowski L, Mattina J, Schonberger S, et al. DICER1 hotspot mutations in non-epithelial gonadal tumours. Br J Cancer 2013; 1-7.
15. Schultz KA, Pacheco MC, Yang J, et al. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: A report from the International Pleuropulmonary Blastoma Registry. Gynecol Oncol 2011; 122:246-250.
16. Slade I, Bacchelli C, Davies H, et al. DICER1 syndrome: Clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet 2011; 48:273-278.
17. Foulkes WD, Bahubeshi A, Hamel N, et al. Extending the phenotypes associated with DICER1 mutations. Hum Mutat 2011; 32:1381-1384.
18. Wu MK, Sabbaghian N. Xu B, et al. Biallelic DICER1 mutations occur in Wilms tumours. J Pathol 230:154-164.
19. Hill DA, Doros L, Schultz KA, et al. DICER1-related disorders. In: RA, Pagon editor. GeneReviews™ [Internet]. Seattle: University of Washington; 2014.
20. Sabbaghian N, Srivastava A, Hamel N, et al. Germ-line deletion in DICER1 revealed by a novel MLPA assay using synthetic oligonucleotides. Eur J Hum Genet 22:564-567.